Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Sho Katsuragawa"'
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 2, Pp 217-225 (2021)
Abstract Aims/Introduction Renal dysfunction might quickly progress in patients with type 2 diabetes mellitus, when accompanied by hypertension. However, whether primary aldosteronism (PA), which autonomously over‐secretes aldosterone, causes addit
Externí odkaz:
https://doaj.org/article/451dc5bf97954c309e9962ddafe18456
Autor:
Haremaru Kubo, Yuya Tsurutani, Kosuke Inoue, Kazuki Watanabe, Yuto Yamazaki, Takashi Sunouchi, Yoshitomo Hoshino, Rei Hirose, Sho Katsuragawa, Hiromitsu Tannai, Yukiko Shibahara, Yukio Kakuta, Seishi Matsui, Jun Saito, Masao Omura, Hironobu Sasano, Tetsuo Nishikawa
Publikováno v:
PLoS ONE, Vol 17, Iss 4, p e0267732 (2022)
Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism. While some cases of PA with unsuppressed PRA were reported, there have been no studies about the characteristics of PA with u
Externí odkaz:
https://doaj.org/article/cb6b2541ded04138b995959c602fca4b
Autor:
Takuhei, Hitsuwari, Yuya, Tsurutani, Takahiro, Yamane, Takashi, Sunouchi, Hirofumi, Horikoshi, Rei, Hirose, Yoshitomo, Hoshino, Satoshi, Watanabe, Sho, Katsuragawa, Jun, Saitou
Publikováno v:
Internal Medicine. 61:3069-3075
Thyrotoxicosis and sodium-glucose transport protein 2 inhibitors (SGLT2is) are associated with the induction of euglycemic diabetic ketoacidosis (euDKA). We herein report two cases of euDKA in patients with diabetes mellitus wherein both thyrotoxicos
Autor:
Sho Katsuragawa, Atsushi Goto, Satoru Shinoda, Kosuke Inoue, Kazuki Nakai, Jun Saito, Tetsuo Nishikawa, Yuya Tsurutani
Publikováno v:
Hypertension (0194911X); Sep2023, Vol. 80 Issue 9, p1909-1920, 12p
Publikováno v:
Journal of General Internal Medicine. 37:1648-1657
An inappropriately low frequency of healthcare utilization has been reported to be associated with poor control of chronic diseases, accelerating healthcare disparities. However, the evidence is limited regarding the association between no healthcare
Publikováno v:
Journal of Diabetes Investigation, Vol 12, Iss 2, Pp 217-225 (2021)
Journal of Diabetes Investigation
Journal of Diabetes Investigation
Aims/Introduction Renal dysfunction might quickly progress in patients with type 2 diabetes mellitus, when accompanied by hypertension. However, whether primary aldosteronism (PA), which autonomously over‐secretes aldosterone, causes additional ren
Autor:
Haremaru Kubo, Yuya Tsurutani, Takashi Sunouchi, Yoshitomo Hoshino, Rei Hirose, Sho Katsuragawa, Noriko Kimura, Jun Saito, Tetsuo Nishikawa
Publikováno v:
Journal of Clinical Medicine. 11:4624
Pheochromocytoma (PCC) is rare catecholamine-producing endocrine tumor that metastasizes in approximately 10% of cases. As a functional imaging of PCC, 123I-metaiodobenzylguanidine (MIBG) scintigraphy was established, and some cases of PCC exhibit ne
Autor:
Haremaru Kubo, Yuya Tsurutani, Kosuke Inoue, Kazuki Watanabe, Yuto Yamazaki, Takashi Sunouchi, Yoshitomo Hoshino, Rei Hirose, Sho Katsuragawa, Hiromitsu Tannai, Yukiko Shibahara, Yukio Kakuta, Seishi Matsui, Jun Saito, Masao Omura, Hironobu Sasano, Tetsuo Nishikawa
Publikováno v:
PloS one. 17(4)
Primary aldosteronism (PA) usually accompanies suppressed plasma renin activity (PRA) through a negative feedback mechanism. While some cases of PA with unsuppressed PRA were reported, there have been no studies about the characteristics of PA with u
Autor:
Jun Saitou, Tomoko Takiguchi, Haremaru Kubo, Rei Hirose, Sho Katsuragawa, Hiroko Yukawa, Naoko Yamamoto, Hitoshi Arioka, Tetsuo Nishikawa, Yoshitomo Hoshino, Takashi Sunouchi, Yuya Tsurutani, Masahiro Ichikawa
Publikováno v:
Internal Medicine
A 77-year-old-man with renal cell carcinoma who was undergoing nivolumab treatment visited our department due to hyperglycemia; his plasma glucose level was 379 mg/dL. Although his serum C-peptide immunoreactivity (CPR) level was preserved (5.92 ng/m
Publikováno v:
Journal of the Endocrine Society
Background and Aim: Glycated albumin (GA) reflects a short-term glycemic control (about 2 weeks) in comparison to glycated hemoglobin (HbA1c) which reflects a long-term glycemic control. Thus, if the dietary, exercise, or medication therapy before th